Acronym
MoST 8 (substudies 19-20 & 35-36)
Project Title
Single arm, open label, signal seeking, phase IIa trial of the activity of Trastuzumab emtansine (T-DM1) in patients with tumours harbouring HER2 amplifications or mutations
Principal Investigator
Start Date
December 11, 2019
Keywords
Cancer/HER2 amplifications or mutations
Project Type
Interventional/Clinical trials research
